Nuvation Bio INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
NUVB
Nuvation Bio INCSCHEDULE 13G: BlackRock Discloses 6.4% Stake in Nuvation Bio Inc.
BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 6.4% in Nuvation Bio Inc.'s common stock as of June 30, 2025.
NYSE
NUVB
Nuvation Bio INCSCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 15% Stake in Nuvation Bio Inc. Class A Common Stock
FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 15.0% of Nuvation Bio Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
NUVB
Nuvation Bio INCBlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Nuvation Bio Inc.'s Class A Stock as of March 31, 2025.
NYSE
NUVB
Nuvation Bio INCFMR LLC and its affiliates, along with Abigail P. Johnson, reported a continued beneficial ownership of 13.5% of Nuvation Bio Inc.'s Class A Common Stock as of December 31, 2024.